article thumbnail

Key developments in pharmaceutical manufacturing – September 2023

European Pharmaceutical Review

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Research by the Confederation of British Industry (CBI) , released in September this year, highlighted progress for UK manufacturing in its latest Industrial Trends Survey. Kerry, Ireland.

article thumbnail

Pharma Horizons: Artificial Intelligence

European Pharmaceutical Review

The first in our inaugural Pharma Horizons report series is dedicated to exploring the latest advances in artificial intelligence (AI) and machine learning (ML) for drug development, pharmaceutical manufacturing and quality control. Additionally the pharmaceutical AI market is projected to reach $11.8

Pharma 130
article thumbnail

As pharma abandons the antibiotic market patients are at risk

World of DTC Marketing

A pull strategy is needed with financial incentives to repair the broken market for antibiotics and make it worthwhile for the pharma industry to bring promising drugs to market. Pew Internet reminds us all that, above all, the pharma industry is a business. The pharma industry is warning of the consequences of inaction. “If

Marketing 174
article thumbnail

Big Pharma inventory management trends revealed

European Pharmaceutical Review

The inventory position of 28 major pharmaceutical manufacturers in 2022 has been revealed in an annual report. Analysis explored the impact of macro-trends on inventory management from corporate reports of Big Pharma companies including Merck, AstraZeneca and Pfizer.

article thumbnail

Pharma unite to secure renewable energy in key manufacturing markets

European Pharmaceutical Review

This step is important as these countries are key markets for pharmaceuticals manufacturing. GSK propels its progress to Net Zero Renewable energy in the pharma supply chain The SMI Health Systems Task Force is a public-private partnership launched at COP26.

article thumbnail

Innovating pharma at the edge

European Pharmaceutical Review

A recent report from the International Data Corporation (IDC), based on extensive research in pharma and life sciences, highlights the requirement for increased operational efficiency and explores the key drivers that are encouraging innovation for pharma companies, now and into the future.

Pharma 98
article thumbnail

Common pharma compliance concerns cited by FDA warning letters

European Pharmaceutical Review

Warning letters issued by FDA can be an important source of data to study and analyse violations that occur in pharmaceutical manufacturing. The post Common pharma compliance concerns cited by FDA warning letters appeared first on European Pharmaceutical Review. What can we learn from contamination control failures?

FDA 105